1-6 of 6
Marc Sorigue
Close
Sort by
Journal Articles

CD34 + CD19 − CD22 + B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies

Brief Report
Clara Bueno, Susana Barrera, Alex Bataller, Valentín Ortiz-Maldonado, Natalina Elliot, Sorcha O’Byrne, Guanlin Wang, Montse Rovira, Francisco Gutierrez-Agüera, Juan L. Trincado, María González-González, Mireia Morgades, Marc Sorigué, Paloma Bárcena, Samanta Romina Zanetti, Montse Torrebadell, Nerea Vega-Garcia, Susana Rives, Mar Mallo, Francesc Sole, Adam J. Mead, Irene Roberts, Supat Thongjuea, Bethan Psaila, Manel Juan, Julio Delgado, Alvaro Urbano-Ispizúa, Josep María Ribera, Alberto Orfao, Anindita Roy, Pablo Menendez
Journal: Blood
Blood (2022) 140 (1): 38–44.
https://doi.org/10.1182/blood.2021014840
Published: 2022
Includes: Supplemental data
Journal Articles

Idelalisib for Relapsed/Refractory Follicular Lymphoma: Retrospective Study from Spanish Lymphoma Group Geltamo (GELT-IDE-2018-02)

Juan-Manuel Sancho, MD PhD, Olga García, Pablo Mozas, Santiago Mercadal, MD, Eva Donato, MD, Ana Muntañola Prat, MD, Javier Lopez Jimenez, MD, Pascual Fernandez Abellan, PhD, Jose-Angel Hernandez, MD, Maria J. Rodriguez-Salazar, MD, Samuel Romero, MD, Ana Marin Niebla, PhD, Angel Ramirez Payer, Raul Cordoba, MD PhD, Jose Luis Bello, MD, Beatriz Cuevas, MD, Itziar Oiartzabal, MD, Alejandro Martín, MD PhD, Jose Javier Sanchez Blanco, Nicholas Kelleher, MD, Ana Lafuente, MD, Marc Sorigué, MD, López Guillermo Armando, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5249.
https://doi.org/10.1182/blood-2019-125921
Published: 2019
Journal Articles

Risk of Secondary Hematological Malignancies in Patients with Follicular Lymphoma: A Retrospective Analysis of 1045 Patients Treated in the Rituximab Era

Roosa Enni Inkeri Prusila, Marc Sorigue, Aleksi Postila, Petteri Salmi, Taru Tanhua, Susanna Tikkanen, Sakari Kakko, Hanne Kuitunen, Marjukka Pollari, Ilja Nystrand, Milla Kuusisto, Kaija Vasala, Esa Jantunen, Eija Korkeila, Peeter Karihtala, Taina Turpeenniemi-Hujanen, Outi Kuittinen
Journal: Blood
Blood (2018) 132 (Supplement 1): 5330.
https://doi.org/10.1182/blood-2018-99-110129
Published: 2018
Journal Articles

Prevalence, Predictive Factors Therapy and Outcome of Patients with Follicular Lymphoma Refractory to First Line Immunochemotherapy

Marc Sorigue, MD, Juan-Manuel Sancho, Santiago Mercadal, MD, Ruben Fernández-Álvarez, MD, Helena Pomares, MD, Olga Garcia, Eva González-Barca, MD PhD, Esther González-García, MD, Miriam Moreno, MD, Cristina Motlló, MD, Montserrat García, MD, Jose-Tomas Navarro, MD PhD, Eva domingo-Domenech, MD, Evarist Feliu, MD PhD, Anna Sureda, MD PhD, Josep-Maria Ribera, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1510.
https://doi.org/10.1182/blood.V126.23.1510.1510
Published: 2015
Journal Articles

Advanced Stage Hodgkin’s Lymphoma Has More Aggressive Characteristics but Similar Outcome in HIV-Infected Than in HIV-Negative Patients in the Combination Antiretroviral Therapy Era

Jose-Tomas Navarro, MD PhD, Marc Sorigue, MD, Blanca Xicoy, MD PhD, Olga Garcia, Maria Joao Baptista, PhD, Juan-Manuel Sancho, MD PhD, Jose-Luis Mate, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4435.
https://doi.org/10.1182/blood.V124.21.4435.4435
Published: 2014
Journal Articles

Frequency and Prognosis of JAK2 V617F, Calr , MPL and ASXL1 Mutations in Primary Myelofibrosis

Marc Sorigue, MD, Marta Cabezón, Olga Garcia, Patricia Velez, MD, Silvia Marce, PhD, Concha Boqué, MD PhD, Blanca Xicoy, MD PhD, Cristalina Fernandez, MD, Marisol Xandri, Enric Casanova, David Gallardo, MD PhD, Fuensanta Milla, MD PhD, Josep-Maria Ribera, MD PhD, Evarist Feliu, MD PhD, Lurdes Zamora, PhD
Journal: Blood
Blood (2014) 124 (21): 5562.
https://doi.org/10.1182/blood.V124.21.5562.5562
Published: 2014